Headache Relief Extra Strength

Generic: Acetaminophen, Aspirin, Caffeine

Labeler: TOP CARE (Topco Associates LLC)
NDC Directory HUMAN OTC DRUG OTC MONOGRAPH DRUG Inactive

Drug Facts

Product Profile

Brand Name Headache Relief Extra Strength
Generic Name Acetaminophen, Aspirin, Caffeine
Labeler TOP CARE (Topco Associates LLC)
Dosage Form TABLET
Routes
ORAL
Active Ingredients

ACETAMINOPHEN 250 mg/1, ASPIRIN 250 mg/1, CAFFEINE 65 mg/1

Identifiers & Regulatory

Product NDC 36800-525
Product ID 36800-525_ad2e8bba-55d5-4c34-87f1-23742de17030
Product Type HUMAN OTC DRUG
Marketing Category OTC MONOGRAPH DRUG
Application Number M013
Marketing Start 2016-07-15
Marketing End 2026-02-15

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 36800525
Hyphenated Format 36800-525

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name Headache Relief Extra Strength (source: ndc)
Generic Name Acetaminophen, Aspirin, Caffeine (source: ndc)
Application Number M013 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 250 mg/1
  • 65 mg/1
source: ndc
Packaging
  • 1 BOTTLE, PLASTIC in 1 BOX (36800-525-10) / 100 TABLET in 1 BOTTLE, PLASTIC
source: ndc

Packages (1)

36800-525-10 1 BOTTLE, PLASTIC in 1 BOX (36800-525-10) / 100 TABLET in 1 BOTTLE, PLASTIC

Ingredients (3)

ACETAMINOPHEN (250 mg/1) ASPIRIN (250 mg/1) CAFFEINE (65 mg/1)

Linked Drug Pages (1)

Headache Relief Extra Strength ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "ad2e8bba-55d5-4c34-87f1-23742de17030", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832", "N0000175739", "N0000175729", "N0000175790", "M0023046"], "upc": ["0036800147584"], "unii": ["362O9ITL9D", "R16CO5Y76E", "3G6A5W338E"], "rxcui": ["308297"], "spl_set_id": ["fb6bca25-8d03-4fa5-a3a8-e595fe089a22"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]", "Xanthines [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]", "Central Nervous System Stimulation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Central Nervous System Stimulant [EPC]", "Methylxanthine [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["TOP CARE (Topco Associates LLC)"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE, PLASTIC in 1 BOX (36800-525-10)  / 100 TABLET in 1 BOTTLE, PLASTIC", "package_ndc": "36800-525-10", "marketing_end_date": "20260215", "marketing_start_date": "20160715"}], "brand_name": "Headache Relief Extra Strength", "product_id": "36800-525_ad2e8bba-55d5-4c34-87f1-23742de17030", "dosage_form": "TABLET", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Methylxanthine [EPC]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Xanthines [CS]"], "product_ndc": "36800-525", "generic_name": "Acetaminophen, Aspirin, Caffeine", "labeler_name": "TOP CARE (Topco Associates LLC)", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Headache Relief", "brand_name_suffix": "Extra Strength", "active_ingredients": [{"name": "ACETAMINOPHEN", "strength": "250 mg/1"}, {"name": "ASPIRIN", "strength": "250 mg/1"}, {"name": "CAFFEINE", "strength": "65 mg/1"}], "application_number": "M013", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_end_date": "20260215", "marketing_start_date": "20160715"}